Contemporary extended pelvic lymph node dissection for prostate cancer in the UK – an analysis of national practice

Contemporary extended pelvic lymph node dissection for prostate cancer in the UK – an analysis of national practice

Extended pelvic lymph node dissection (ePLND) is accepted as the optimal method of lymph node staging in prostate cancer. In the UK radical prostatectomy has been performed in specialist centres since 2002. Since 2014 as part of a NHS transparency drive, contributing data to the BAUS national regist...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Calleja, E, Reilly, G, Fowler, S, McGrath, J, Sooriakumaran, P, Aning, J
Materialtyp:	Conference item
Publicerad:	Elsevier 2017

Liknande verk

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended? Of Course Not!
av: Prasanna Sooriakumaran, et al.
Publicerad: (2022-10-01)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
av: Anthony Van Baelen, et al.
Publicerad: (2012-01-01)

Extended Salvage Pelvic Lymph Node Dissection in Patients with Recurrent Prostate Cancer
av: Daniar K. Osmonov, et al.
Publicerad: (2014-01-01)

Outcomes of robot-assisted laparoscopic extended pelvic lymph node dissection for prostate Cancer
av: Silvan Sigg, et al.
Publicerad: (2024-01-01)

Robotic Assisted Template Extended Pelvic Lymph Node Dissection
av: Daly Killian, et al.
Publicerad: (2020-09-01)

Pelvic lymph node dissection in high-risk prostate cancer
av: Luciano Haiquel, et al.
Publicerad: (2022-01-01)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
av: Giorgio Gandaglia, et al.
Publicerad: (2022-10-01)

Current status and therapeutic value of extended pelvic lymph node dissection during radical prostatectomy for prostate cancer
av: Shuichi Morizane, et al.
Publicerad: (2024-09-01)

Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection
av: Zhen Li, et al.
Publicerad: (2023-05-01)

High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection
av: Antonio B Porcaro, et al.
Publicerad: (2020-01-01)

Prospective evaluation of pelvic lymph node staging with 18fluorine prostate-specific membrane antigen PET/CT prior to extended lymph node dissection in primary prostate cancer – the SALT trial
av: B.H.E. Jansen, et al.
Publicerad: (2020-07-01)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended or Not. The Referee Point of View
av: Marlon Perera, et al.
Publicerad: (2022-10-01)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
av: Piotr Jarzemski, et al.
Publicerad: (2020-02-01)

When the limited pelvic lymph node dissection in prostate cancer patients can be justified?
av: R. M. Molchanov, et al.
Publicerad: (2020-10-01)

Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer
av: Guanjie Yang, et al.
Publicerad: (2022-01-01)

Standardized and simplified robot-assisted super extended pelvic lymph node dissection for prostate cancer: The monoblock technique (2019 Update)
av: A. Mattei, et al.
Publicerad: (2020-07-01)

Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection
av: Zhongru Fan, et al.
Publicerad: (2024-01-01)

Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique
av: Giancarlo Albo, et al.
Publicerad: (2024-03-01)

Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection
av: Lisa Moris, et al.
Publicerad: (2016-12-01)

Extended robot‐assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high‐risk prostate cancer Patients
av: Noriyoshi Miura, et al.
Publicerad: (2021-11-01)

The role and controversy of pelvic lymph node dissection in prostate cancer treatment: a focused review
av: Baonan Dong, et al.
Publicerad: (2024-02-01)

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection
av: G. Gandaglia, et al.
Publicerad: (2020-07-01)

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection
av: S. Scuderi, et al.
Publicerad: (2020-10-01)

Protocol for a Pilot Study of the NODE Trial, a Prospective Multicentre Randomised Trial of Extended Pelvic Lymph Node Dissection for High-Risk Prostate Cancer
av: George McClintock, et al.
Publicerad: (2021-11-01)

Correction: Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique
av: Giancarlo Albo, et al.
Publicerad: (2024-04-01)

Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates
av: Naoya Nagaya, et al.
Publicerad: (2023-06-01)

Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis
av: Junru Chen, et al.
Publicerad: (2020-11-01)

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? Results from a large, multi-institutional series
av: C.A. Bravi, et al.
Publicerad: (2020-07-01)

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institutional series
av: C.A. Bravi, et al.
Publicerad: (2020-10-01)

Comparison of morbidity between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized trial
av: K.A. Touijer, et al.
Publicerad: (2020-07-01)

Contemporary use trends and effect on survival of pelvic lymph node dissection for non-muscle-invasive bladder cancer
av: Yaxiong Tang, et al.
Publicerad: (2022-08-01)

External iliac arterial dissection after robot‐assisted radical cystectomy with an intracorporeal ileal conduit and extended pelvic lymph node dissection
av: Syunsuke Nakashima, et al.
Publicerad: (2023-11-01)

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
av: Takuya Oishi, et al.
Publicerad: (2023-03-01)

Complications of Extended Pelvic Lymph Node Dissection in Patients Undergoing Minimally Invasive Radical Prostatectomy: Analysis and Risk Factors
av: Pedro Castro, et al.
Publicerad: (2022-01-01)

Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy
av: Isaac E. Kim, Jr., et al.
Publicerad: (2024-06-01)

Comparison of erectile function recovery between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized trial
av: K.A. Touijer, et al.
Publicerad: (2020-07-01)

Post‐operative incidence of lymphedema after RARP with or without extended pelvic lymph node dissection in a cohort study
av: Andries Clinckaert, et al.
Publicerad: (2025-01-01)

Extended lymph node dissection in robot-assisted radical prostatectomy: lymph node yield and distribution of metastases
av: Kwang Hyun Kim, et al.
Publicerad: (2014-12-01)

Comparison of oncological outcomes between extended and no pelvic lymph node dissection in patients with high- or very high-risk prostate cancer: a multi-institutional study
av: Satoshi Washino, et al.
Publicerad: (2024-09-01)

Laparoscopic Sentinel Lymph Node Biopsy for Prostate Cancer: The Relevance of Locations Outside the Extended Dissection Area
av: W. Meinhardt, et al.
Publicerad: (2012-01-01)